This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Kurt A. Oster, MD
Bridgeport, Conn

JAMA. 1983;249(11):1436.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The risk factorreduction data are derived mainly from the results of the Framingham study. The formula used in that investigation holds that a 10% reduction of the SC level of the US population will effect a 24.4% decrease in CHD incidence and that a 50% SC reduction will result in an incredible 84% reduction of CHD incidence, assuming a linear regression. This formula, erroneously modified from the original publication, equates risk with incidence. These figures are said to be valid for one year only, not for the six years of the MRFIT program. A more correct interpretation should read that CHD is 24.4% less likely to develop in those persons whose SC level is 10% lower than that of the average low-risk population.¹

Also used in arriving at the recommended SC reduction is the Walker-Duncan formula, wherein the figures represented hits, near-misses, and misses against various . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?